Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia

被引:117
作者
Oscier, David [1 ]
Dearden, Claire [2 ]
Erem, Efrem [3 ]
Fegan, Christopher [4 ]
Follows, George [5 ]
Hillmen, Peter [6 ]
Illidge, Tim [7 ]
Matutes, Estella [2 ]
Milligan, Don W. [8 ]
Pettitt, Andrew [9 ]
Schuh, Anna [10 ]
Wimperis, Jennifer [11 ]
机构
[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[2] Royal Marsden Hosp, London SW3 6JJ, England
[3] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
[4] Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales
[5] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[6] St Jamess Inst Oncol, Leeds, W Yorkshire, England
[7] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England
[8] Heart England NHS Foundata Trust, Birmingham, W Midlands, England
[9] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England
[10] Churchill Hosp, Oxford OX3 7LJ, England
[11] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
关键词
chronic lymphocytic leukaemia; small lymphocytic lymphoma; guideline; STEM-CELL TRANSPLANTATION; FLUDARABINE PLUS CYCLOPHOSPHAMIDE; HIGH-DOSE METHYLPREDNISOLONE; PHASE-II TRIAL; PREVIOUSLY UNTREATED PATIENTS; AUTOIMMUNE HEMOLYTIC-ANEMIA; PROGRESSION-FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; QUALITY-OF-LIFE; LRF CLL4 TRIAL;
D O I
10.1111/bjh.12067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:541 / 564
页数:24
相关论文
共 181 条
  • [1] [Anonymous], 1999, J Natl Cancer Inst, V91, P861
  • [2] [Anonymous], BLOOD
  • [3] [Anonymous], ASH ANN M
  • [4] [Anonymous], BLOOD
  • [5] American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
    Artz, Andrew S.
    Somerfield, Mark R.
    Feld, Jordan J.
    Giusti, Andrew F.
    Kramer, Barnett S.
    Sabichi, Anita L.
    Zon, Robin T.
    Wong, Sandra L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3199 - 3202
  • [6] Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia
    Badoux, Xavier C.
    Keating, Michael J.
    Wang, Xuemei
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Faderl, Stefan
    Burger, Jan
    Koller, Charles
    Lerner, Susan
    Kantarjian, Hagop
    Wierda, William G.
    [J]. BLOOD, 2011, 118 (08) : 2085 - 2093
  • [7] Bayrakci B, 2005, TURKISH J PEDIATR, V47, P239
  • [8] Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
    Bene, M. C.
    Nebe, T.
    Bettelheim, P.
    Buldini, B.
    Bumbea, H.
    Kern, W.
    Lacombe, F.
    Lemez, P.
    Marinov, I.
    Matutes, E.
    Maynadie, M.
    Oelschlagel, U.
    Orfao, A.
    Schabath, R.
    Solenthaler, M.
    Tschurtschenthaler, G.
    Vladareanu, A. M.
    Zini, G.
    Faure, G. C.
    Porwit, A.
    [J]. LEUKEMIA, 2011, 25 (04) : 567 - 574
  • [9] A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease
    Best, O. G.
    Gardiner, A. C.
    Davis, Z. A.
    Tracy, I.
    Ibbotson, R. E.
    Majid, A.
    Dyer, M. J. S.
    Oscier, D. G.
    [J]. LEUKEMIA, 2009, 23 (01) : 212 - 214
  • [10] BHIV, 2008, GUID HIV TEST 2008